Sandbox Reserved 1771

From Proteopedia

(Difference between revisions)

Revision as of 21:31, 29 March 2023

This Sandbox is Reserved from February 27 through August 31, 2023 for use in the course CH462 Biochemistry II taught by R. Jeremy Johnson at the Butler University, Indianapolis, USA. This reservation includes Sandbox Reserved 1765 through Sandbox Reserved 1795.

To get started:

Click the edit this page tab at the top. Save the page after each step, then edit it again.
show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

1 IgM B-cell Receptor

IgM B-cell Receptor

Introduction

The human B-cell receptor(BCR) is a complex protein made up of three domains: extracellular, transmembrane, and intracellular. While the extracellular region makes up most of the protein, perhaps the most interesting interactions can be found in the transmembrane domain. Unlike other BCRs, the IgM BCR has a specific heavy chain interaction with the α-β subunit of the protein. BCRs are found on the surface of B-cells as membrane bound proteins (ref). In general the role of BCRs is to bind to foreign antigens and initiate the appropriate immune response.

Structure

The BCR consists of a membrane-bound immunoglobulin (mIg) and two signal-transducing subunits, Igα and Igβ. The mIg consists of two heavy chains and two light chains. Antigen binding at the binding site triggers signal transduction by Igα and Igβ. Both consist of an extracellular, Ig-like domain, and an intracellular immunoreceptor tyrosine-based activation motif. ^[1].

Antigen Binding Site

Figure 1. Overview of the human B Cell Receptor and its structural components. Used with permission under Wikimedia Commons.

The binding of an antigen to the human B Cell receptor is identical to other common soluble antibodies (such as IgG, IgA, IgM, IgE, or IgD). The antibody portion of the B Cell Receptor is roughly "Y" shaped and consists of two identical and two identical chains creating two similar epitope or binding regions. Thus, two antigen molecules can bind independent of one another to produce a response. Within this structure, there are both constant and variable regions. The stem of the "Y" is a (Fc) composed of only heavy chain interactions. The two heavy chains then branch at a flexible . These interact individually with one light chain creating two Fab fragments or branches of the "Y". Each additionally contains a (Fv) and a . The variable region sits on top of the constant region and consists of hyper-variable loops which are random coils of amino acids that are unique to an antibody and exposed to allow specific recognition of an antigen. Furthermore, the light chains interact with the heavy chains via weak intermolecular forces and disulfide bridges. Therefore, binding to an antigen is processed through intermolecular interactions and is specific due to unique hyper variable loop sequences.

Fc and α/β Interactions

While the antigen binding site structure of the mIgM BCR is identical to other common soluble antibodies, there are several intracellular interactions between the heavy chains and Igα/β subunits that make it unique. In the Fc portion of the structure, the two heavy chains interact via a disulfide bond and form an . Additionally, the Fc portion binds the with 1:1 stoichiometry. ^[2]. Due to the orientation of the heavy chains in the O-shaped ring, only Heavy chain 1 (Hc1) forms direct interactions with the Igα/β heterodimer. Furthermore, through two hydrogen bonds (T75-Q487 and N73-Q493) which are stabilized by sandwiching of aromatic residues (W76 sandwiched between F358 and F485). Similarly, through three hydrogen bonds (Y66-R491, K62-T530, and R55-T533,). The residues involved in the interactions at the heavy chain and Igα/β interface are highly conserved across all species, suggesting a conserved mode of interaction. ^[1]. The Igα/β heterodimer is an obligate component of all BCRs. Igα and Igβ non-covalently associate with mIgM, and are crucial components for initiating biochemical signaling inside the B cell upon antigen binding. ^[2]. by a disulfide bond between cystine residues (C119-C136). The disulfide bond is stabilized by π-π stacking (Y122 and F52) and a hydrogen bond (G120-R51). These residues are highly conserved across species, suggesting conservation of the Igα/β interface.

Transmembrane Interactions

Many transmembrane interactions can be found within a IgM B-cell receptor. The have numerous interactions that keep them associated with each other. An overview of all residue interactions can be found (highlighted in green). At a cellular pH, various amino acid residues found in the transmembrane region are charged as well, which strengthens the overall interaction. For example, between residues N155 and E138, along with numerous other hydrogen bonds, works to stabilize the α-β chain interactions. Further down the chains, between residues T166 and E148 also have strong hydrogen bonding. Overall, these hydrogen bonds and ion interactions work to maintain the association of the α-β chains.

Function

Once bound to an antigen, BCRs undergo a conformational change in the extracellular region. While the exact conformational change is still not known, preliminary studies suggest that there is separation of Fab fragments that opens the binding site within the BCR(ref). This initiates several signal transduction pathways, which are responsible for processing the antigen and initiating the appropriate immune responses. More specifically, the α-β subunit is connected to the phosphorylation of an immunoreceptor tyrosine-based activation motif(ITAM) upon binding. This in turn triggers the activation of kinases downstream that aid in the immune response. BCRs can be oligomeric prior to antigen binding, but once bound become an active monomer. ^[3].

Medical Relevancy

B-cell Formation

The formation of B-cells occurs in the bone marrow from hematopoietic stem cells^[4]. Once formed, B-cell receptors are attached to B-cells through the aid of membrane-bound proteins in bone marrow cells. During this process, gene recombination occurs, which allows unique BCRs to become highly specific to different antigens.

Diseases

Therapeutics

References

↑ ^1.0 ^1.1 Su Q, Chen M, Shi Y, Zhang X, Huang G, Huang B, Liu D, Liu Z, Shi Y. Cryo-EM structure of the human IgM B cell receptor. Science. 2022 Aug 19;377(6608):875-880. [doi: 10.1126/science.abo3923. Epub 2022 Aug 18. PMID: 35981043.]
↑ ^2.0 ^2.1 Tolar P, Pierce SK. Unveiling the B cell receptor structure. Science. 2022 Aug 19;377(6608):819-820. [doi: 10.1126/science.add8065. Epub 2022 Aug 18. PMID: 35981020.]
↑ ShenSichen Z, LiZhengpeng L, Liu W,(2019) Conformational change within the extracellular domain of B cell receptor in B cell activation upon antigen binding [eLife 8:e42271. https://doi.org/10.7554/eLife.42271]
↑ Althwaiqeb, S. Histology, B Cell Lymphocyte; StatPearls Publishing, 2023.

Retrieved from "http://52.214.119.220/wiki/index.php/Sandbox_Reserved_1771"

@@ Line 19: / Line 19: @@
 ==Function==
-Once bound to an antigen, BCRs undergo a conformational change in the extracellular region. While the exact conformational change is still not known, preliminary studies suggest that there is separation of Fab fragments that opens the binding site within the BCR(ref). This initiates several signal transduction pathways, which are responsible for processing the antigen and initiating the appropriate immune responses. More specifically, the α-β subunit is connected to the phosphorylation of an [https://en.wikipedia.org/wiki/Immunoreceptor_tyrosine-based_activation_motif immunoreceptor tyrosine-based activation motif](ITAM) upon binding. This in turn triggers the activation of kinases downstream that aid in the immune response. BCRs can be oligomeric prior to antigen binding, but once bound become an active monomer.
+Once bound to an antigen, BCRs undergo a conformational change in the extracellular region. While the exact conformational change is still not known, preliminary studies suggest that there is separation of Fab fragments that opens the binding site within the BCR(ref). This initiates several signal transduction pathways, which are responsible for processing the antigen and initiating the appropriate immune responses. More specifically, the α-β subunit is connected to the phosphorylation of an [https://en.wikipedia.org/wiki/Immunoreceptor_tyrosine-based_activation_motif immunoreceptor tyrosine-based activation motif](ITAM) upon binding. This in turn triggers the activation of kinases downstream that aid in the immune response. BCRs can be oligomeric prior to antigen binding, but once bound become an active monomer.  <Ref name="ShenSichen Z"> ShenSichen Z, LiZhengpeng L, Liu W,(2019) Conformational change within the extracellular domain of B cell receptor in B cell activation upon antigen binding [eLife 8:e42271. https://doi.org/10.7554/eLife.42271]</Ref>.
 ==Medical Relevancy==